NPR News

Pages

Opinion
10:20 am
Wed July 18, 2012

Weekly Standard: Time To Get Tough With The Banks

Republican presidential candidate Mitt Romney speaks at a campaign rally at Horizontal Wireline Services July 17 in Irwin, Penn.
Win McNamee Getty Images

Irwin M. Stelzer is a contributing editor to The Weekly Standard, director of economic policy studies at the Hudson Institute, and a columnist for the Sunday Times (London).

Read more
Opinion
10:20 am
Wed July 18, 2012

The New Republic: Where's The Outrage Over LIBOR?

The Canary Wharf headquarters of Barclays Bank, who have been more than $450 for manipulating the LIBOR inter-bank lending rate, on June 28 in London, England. British Prime Minister David Cameron has said the bank's management has 'serious questions' to answer regarding their practices.
Oli Scarff Getty Images

Noam Scheiber is a senior editor at The New Republic.

Read more
Opinion
10:19 am
Wed July 18, 2012

The Nation: Can LIBOR Force U.S. Banking Reform?

Federal Reserve Board Chairman Ben Bernanke testifies before the Senate Banking, Housing and Urban Affairs Committee on Capitol Hill July 17 in Washington, D.C.
Chip Somodevilla Getty Images

John Nichols is a Washington correspondent at The Nation.

As lies go, none is greater than the one that suggests banks are capable of "self-regulation."

Given authority over their own affairs, through fantasies such as "self-reporting," CEOs, CFOs and COOs who travel in limousines, wear very expensive suits and give to all the right charities will do what comes naturally to them: lie.

Read more
The Two-Way
9:46 am
Wed July 18, 2012

Heir To Billions Charged With Preventing Wife's Burial, Not Murder

Hans Kristian Rausing as he arrived at court earlier today.
Facundo Arrizabalaga EPA /Landov

Though he had been arrested on suspicion of murder, the son of a Swedish billionaire has only been charged with "preventing the lawful and decent burial of the body of his wife," The Guardian reports.

Read more
Shots - Health Blog
9:11 am
Wed July 18, 2012

FDA Approves Second Diet Drug In A Month

The range of Qsymia doses approved by the Food and Drug Administration Tuesday.
AP

Originally published on Wed July 18, 2012 4:14 pm

After a 13-year hiatus, the Food and Drug Administration gave its OK to the second weight-loss drug in a month.

This time it's Qsymia, previously called Qnexa, from Vivus. The pill contains two active ingredients: topiramate, an anti-seizure medicine, and phentermine, a stimulant.

Read more

Pages